SARAJEVO (Bosnia and Herzegovina), August 4 (SeeNews) – Bosnia’s biggest pharmaceutical company, Bosnalijek, said its first-half net profit fell 29% on the year to 3.7 million Bosnian marka ($2.7 million/1.9 million euro).